EP3341015
ENHANCED DEPLETION OF TARGETED CELLS WITH CD47 BLOCKADE AND AN IMMUNE COSTIMULATORY AGONIST
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.8.2016EP published:
28.7.2021EP application number:
16840215.4
EPO information:
European Patent Register
Max expiry date:
25.8.2036
Title:
ENHANCED DEPLETION OF TARGETED CELLS WITH CD47 BLOCKADE AND AN IMMUNE COSTIMULATORY AGONIST
Timeline
Today
26.8.2016EP application
28.7.2021EP Publication
Owner
Name:
The Board of Trustees of the Leland Stanford Junior UniversityAddress:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US
Inventor
Name:
SCHNORR, PeterAddress:
Sudbury, Massachusetts 01776, US
Name:
CHHABRA, AkankshaAddress:
San Francisco, California 94117, US
Name:
SHIZURU, Judith A.Address:
Palo Alto, California 94301, US
Name:
WEISSMAN, Irving L.Address:
Stanford, California 94305, US
Name:
WEISKOPF, Kipp AndrewAddress:
Sudbury, Massachusetts 01776, US
Priority
Number:
201562210279 PDate:
26.8.2015Country:
US
Classification
Categories:
A61K 39/00, A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30